These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8912167)

  • 21. Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
    Nikoomanesh F; Falahatinejad M; Černáková L; Dos Santos ALS; Mohammadi SR; Rafiee M; Rodrigues CF; Roudbary M
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109701
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
    Ge SH; Wan Z; Li J; Xu J; Li RY; Bai FY
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the diagnosis and treatment of recurrent vulvovaginal candidiasis in 80 cases].
    Yuan XR; Li HW; Yuan L; Fan LZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2413-4, 2416. PubMed ID: 20965860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis.
    Avijgan M; Mahboubi M; Moheb Nasab M; Ahmadi Nia E; Yousefi H
    J Mycol Med; 2014 Jun; 24(2):112-6. PubMed ID: 24746726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
    Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
    PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
    Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
    Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
    Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F
    Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fungi isolated from the vagina and their susceptibility to antifungals].
    Macura AB; Skóra M
    Ginekol Pol; 2012 Jun; 83(6):433-8. PubMed ID: 22880463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.
    Consolaro ME; Albertoni TA; Svidzinski AE; Peralta RM; Svidzinski TI
    Mycopathologia; 2005 Jun; 159(4):501-7. PubMed ID: 15983735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining Susceptibility in
    Sobel JD; Akins R
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0236621. PubMed ID: 35604210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.
    Spitzer M; Wiederhold NP
    J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.
    Collins LM; Moore R; Sobel JD
    J Low Genit Tract Dis; 2020 Jan; 24(1):48-52. PubMed ID: 31860575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.